Cancer chemoprevention by a combination of white tea plus sulindac in a mouse model expressing an oncogenic form of β-catenin.

被引：0
|
作者：
Orner, G
Dashwood, WM
Tebbutt, NC
Li, Q
Heath, JK
Myzak, MC
Ernst, M
Dashwood, RH
机构：
[1] Oregon State Univ, Corvallis, OR 97331 USA
[2] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2003年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1287S / 1287S
页数：1
相关论文
共 19 条
  • [1] Suppression of tumorigenesis in the Apcmin mouse:: down-regulation of β-catenin signaling by a combination of tea plus sulindac
    Orner, GA
    Dashwood, WM
    Blum, CA
    Díaz, GD
    Li, QJ
    Dashwood, RH
    CARCINOGENESIS, 2003, 24 (02) : 263 - 267
  • [2] Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice
    Suganuma, M
    Ohkura, Y
    Okabe, S
    Fujiki, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 69 - 72
  • [3] Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice
    Masami Suganuma
    Yasuo Ohkura
    Sachiko Okabe
    Hirota Fujiki
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 69 - 72
  • [4] Loss of GDF-15 abolishes Sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer
    Zimmers, Teresa A.
    Gutierrez, Juan C.
    Koniaris, Leonidas G.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (04) : 571 - 576
  • [5] Loss of GDF-15 abolishes Sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer
    Teresa A. Zimmers
    Juan C. Gutierrez
    Leonidas G. Koniaris
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 571 - 576
  • [6] Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model
    Chandra, Swati
    Nymeyer, Ariel C.
    Rice, Photini Faith
    Gerner, Eugene W.
    Barton, Jennifer K.
    CANCER PREVENTION RESEARCH, 2017, 10 (08) : 459 - 466
  • [7] Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
    Davis, Jennifer S.
    Kanikarla-Marie, Preeti
    Gagea, Mihai
    Yu, Patrick L.
    Fang, Dexing
    Sebastian, Manu
    Yang, Peiying
    Hawk, Ernest
    Dashwood, Roderick
    Lichtenberger, Lenard M.
    Menter, David
    Kopetz, Scott
    BMC CANCER, 2020, 20 (01)
  • [8] Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
    Jennifer S. Davis
    Preeti Kanikarla-Marie
    Mihai Gagea
    Patrick L. Yu
    Dexing Fang
    Manu Sebastian
    Peiying Yang
    Ernest Hawk
    Roderick Dashwood
    Lenard M. Lichtenberger
    David Menter
    Scott Kopetz
    BMC Cancer, 20
  • [9] Efficacy of Dimethylaminoparthenolide and Sulindac in Combination With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
    Yip-Schneider, Michele T.
    Wu, Huangbing
    Hruban, Ralph H.
    Lowy, Andrew M.
    Crooks, Peter A.
    Schmidt, Christian Max
    PANCREAS, 2013, 42 (01) : 160 - 167
  • [10] Combination of selenium and green tea improves the efficacy of chemoprevention of selenium and green tea alone in a rat colon cancer model
    Hu, Y.
    Le Leu, R. K.
    Nyskohus, L. S.
    Winter, J.
    Young, G. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A73 - A74
12